Page last updated: 2024-10-24

carteolol and Anochlesia

carteolol has been researched along with Anochlesia in 1 studies

Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Research Excerpts

ExcerptRelevanceReference
"Neuroleptic-induced catalepsy, a model of neuroleptic-induced extrapyramidal side effects, was considered suitable as a model for predicting neuroleptic-induced akathisia in humans, although neuroleptic-induced catalepsy was not considered a specific test for neuroleptic-induced akathisia."1.30The attenuating effect of carteolol hydrochloride, a beta-adrenoceptor antagonist, on neuroleptic-induced catalepsy in rats. ( Kikuchi, T; Morita, S; Nakai, M; Tottori, K; Uwahodo, Y, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kikuchi, T1
Uwahodo, Y1
Tottori, K1
Nakai, M1
Morita, S1

Other Studies

1 other study available for carteolol and Anochlesia

ArticleYear
The attenuating effect of carteolol hydrochloride, a beta-adrenoceptor antagonist, on neuroleptic-induced catalepsy in rats.
    Psychopharmacology, 1997, Volume: 131, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Antipsychotic Agents; Carteolol; Catalepsy; Haloperidol; Locom

1997